GlassScriptPhysician profile
Steve Chausse
NPI 1083008346
$5,441.59
in general payments reported to CMS, 2019-2025
26 companies · $577 in 2025
The $577 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2021: $880 · 2022: $1,794 · 2023: $1,413 · 2024: $615 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,685.42 | 2022-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $430.79 | 2019-2023 | Xact, Jeti |
| Medtronic, INC. | $374.37 | 2023-2025 | Heli-Fx Endoanchor System, Endurant Iis, Venaseal |
| Silk Road Medical, INC. | $347.28 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Penumbra, INC. | $347.11 | 2021-2024 | Penumbra System |
| W. L. Gore & Associates, INC. | $289.10 | 2021-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Inari Medical, INC. | $271.91 | 2021-2022 | |
| Lemaitre Vascular, INC. | $263.85 | 2021-2025 | Artegraft Vascular Graft, Restoreflow |
| Boston Scientific Corporation | $261.99 | 2022-2025 | Enroute Transcarotid Neuroprotection System |
| Stryker Corporation | $246.49 | 2025 | Artix Mt, Flowtriever, Venacore Thrombectomy Catheter |
| Janssen Pharmaceuticals, INC | $204.45 | 2021-2024 | Xarelto |
| Cook Medical LLC | $202.92 | 2022 | |
| Philips North America LLC | $100.40 | 2021-2023 | |
| Surmodics, INC. | $71.57 | 2023-2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Cardiovascular Systems INC. | $65.34 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $39.49 | 2025 | |
| Acera Surgical, INC. | $35.22 | 2024-2025 | Restrata Wound Matrix |
| Baxter Healthcare | $32.10 | 2024-2025 | Preveleak |
| Cardiva Medical, INC. | $30.76 | 2022 | |
| Ethicon US, LLC | $28.64 | 2024 | Surgicel Nu-Knit |
| Biotissue Holdings INC. | $23.46 | 2024 | |
| Imperative Care, INC | $21.19 | 2023 | Symphony Catheter |
| Abbvie INC. | $18.83 | 2023 | Dalvance |
| Heron Therapeutics, INC. | $17.17 | 2024 | Zynrelef |
| Bolton Medical INC | $16.14 | 2024 | |
| Solventum Corporation | $15.60 | 2024 | V.A.C.Instill, Activ.A.C., Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Chausse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.